Searle & Co. PROGENICS PHARMACEUTICALS IN Transaction History

Searle & Co.

  • $396 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 25, 2018
SELL
N/A
-14,500 Closed
0 $0
Q3 2017

Oct 27, 2017
BUY
N/A
14,500
14,500 $107,000
Track This Portfolio

Track Searle & Co. Portfolio

Follow Searle & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email